BackParabilis Medicines Overview

Parabilis Medicines Current Cash

Parabilis Medicines's current cash is $1.1B.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.09B

Peer trimmed avg / median

Loading

Parabilis Medicines Current Cash History

Loading

Parabilis Medicines vs. peers: Current Cash Comparison

Loading

Parabilis Medicines Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Parabilis Medicines (PBLS) FAQ

The latest current cash for PBLS is $1.1B as of June 2026. Investors often review this figure alongside Parabilis Medicines's historical trend and sector peers before judging valuation or financial health.

A current cash figure of $1.1B for PBLS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PBLS's current cash ($1.1B), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Parabilis Medicines's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.